Magnesium Sulfate vs Placebo for Placental Abruption

Trial ID or NCT#

NCT00186069

Status

not recruiting iconNOT RECRUITING

Purpose

To evaluate the safety and efficacy of magnesium sulfate for preterm suspected abruption.

Official Title

Randomized, Double Blind Trial of Magnesium Sulfate Tocolysis Versus Intravenous Saline for Suspected Placental Abruption

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: Female
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. - vaginal bleeding and contractions consistent with suspected placental abruption between 24 and 34 weeks gestation.
Exclusion Criteria:
  1. - preterm labor, severe bleeding necessitating immediate delivery, maternal coagulopathy, fetal distress
View All Criteria
Show Less

Investigator(s)

Yasser El-Sayed, Professor
Yasser El-Sayed, Professor
Obstetrician and Gynecologist (OB-GYN)
Charles B. and Ann L. Johnson Professor in the School of Medicine and Professor, by courtesy, of Pediatrics (Neonatology) and of Surgery

Contact us to find out if this trial is right for you.

Contact

Iris Colon, MD
(408) 855-5550

View on ClinicalTrials.gov